Corrigendum to “Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics” [Curr. Opin. Pharmacol. 30 (2016) 93–105]
Chang K, Liu M. Corrigendum to “Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics” [Curr. Opin. Pharmacol. 30 (2016) 93–105]. Current Opinion In Pharmacology 2016, 30: 158-159. PMID: 27707534, DOI: 10.1016/j.coph.2016.09.005.Peer-Reviewed Original ResearchChronic hepatitis B: immune pathogenesis and emerging immunotherapeutics
Chang K, Liu M. Chronic hepatitis B: immune pathogenesis and emerging immunotherapeutics. Current Opinion In Pharmacology 2016, 30: 93-105. PMID: 27570126, DOI: 10.1016/j.coph.2016.07.013.Peer-Reviewed Original ResearchConceptsImmune modulatory approachesChronic hepatitis B.Chronic viral infectionsHost immune componentsImmune pathogenesisHBV infectionFunctional cureHepatitis BHepatitis B.Tumor immunotherapyModulatory approachesImmune componentsImmune interactionsClinical developmentViral infectionDisease pathogenesisNatural historyPathogenic responsesAspects of hostImmunotherapeuticsPathogenesisTumor therapyInfectionImmunotherapyTherapy